Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

29.77USD
10:56am EDT
Price Change (% chg)

$-0.04 (-0.13%)
Prev Close
$29.81
Open
$29.95
Day's High
$30.00
Day's Low
$29.46
Volume
318,472
Avg. Vol
1,679,969
52-wk High
$35.40
52-wk Low
$28.97

ZTS.N

Chart for ZTS.N

About

Zoetis Inc, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs,... (more)

Overall

Beta: --
Market Cap (Mil.): $14,905.00
Shares Outstanding (Mil.): 500.00
Dividend: 0.06
Yield (%): 0.87

Financials

  ZTS.N Industry Sector
P/E (TTM): 32.06 37.93 37.76
EPS (TTM): 0.93 -- --
ROI: 9.35 19.48 18.76
ROE: 20.03 20.17 19.59
Search Stocks

Pfizer says shareholders snap up remaining Zoetis shares

- Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.

24 Jun 2013

UPDATE 2-Pfizer says shareholders snap up remaining Zoetis shares

June 24 - Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.

24 Jun 2013

Pfizer says shareholders snap up remaining Zoetis shares

June 24 - Pfizer Inc said on Monday that enough Pfizer shareholders offered to trade their shares for stock in Pfizer's majority owned Zoetis Inc animal health business to allow Pfizer to complete its spinoff of the unit.

24 Jun 2013

Pfizer to spin off Zoetis stake to shareholders

- Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

22 May 2013

UPDATE 2-Pfizer to spin off Zoetis stake to shareholders

May 22 - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

22 May 2013

BRIEF-Pfizer up in premarket after plans to unwind remaining majority stake in Zoetis

NEW YORK, May 22 - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis

22 May 2013

Strong pet product sales help Zoetis top estimates

- Zoetis Inc , formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in the United States.

30 Apr 2013

UPDATE 2-Strong pet product sales help Zoetis top estimates

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in the United States.

30 Apr 2013

Zoetis profit beats Street on strong pet product sales

- Zoetis Inc , formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.

30 Apr 2013

Zoetis profit beats Street on strong pet product sales

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.

30 Apr 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00
Provider: Wright Reports
$368.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks